Omar, Amer http://orcid.org/0000-0003-1520-392X
Williams, R. Geoff http://orcid.org/0000-0002-6747-3473
Whelan, James
Noble, Jason
Brent, Michael H. http://orcid.org/0000-0002-8720-5185
Giunta, Michel
Olivier, Sébastien
Lhor, Mustapha
Funding for this research was provided by:
Bayer
Article History
Received: 31 January 2024
Accepted: 29 February 2024
First Online: 23 March 2024
Declarations
:
: Amer Omar worked as a consultant for Bayer, Roche, and Apellis. R. Geoff Williams served on advisory boards for Novartis, Bayer, Alcon, Valeant, Allergan, and AbbVie; received financial support from MD Collaborate and Arctic Dx; and worked as an investigator for Novartis, Bayer, Allergan, Regeneron, and Abbott Labs. James Whelan received honoraria from Bayer, Novartis, and Roche. Jason Noble served on the advisory board for Roche, Biogen, and Apellis. Michael H. Brent worked as a consultant for Bayer, Roche, Apellis, and Novartis. Michel Giunta worked as a consultant for Bayer, Roche, Apellis, Novartis, and Alcon. Sébastien Olivier had no declarations. Mustapha Lhor is a Bayer employee.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.